✦ LIBER ✦

Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study

✍ Scribed by Eric Van Den Neste, Bruno Cazin, Ann Janssens…

Book ID: 120776581
Publisher: Springer
Year: 2012
Tongue: English
Weight: 325 KB
Volume: 71
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-012-2033-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bendamustine Combined With Rituximab in

Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Stilgenbauer, S.; Bahlo, J.; Schweighofer, C 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 141 KB

Phase II Study of Dasatinib in Relapsed

Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

✍ Amrein, P. C.; Attar, E. C.; Takvorian, T.; Hochberg, E. P.; Ballen, K. K.; Leah 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 659 KB

Phase II Study of Lenalidomide and Ritux

Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

✍ Badoux, X. C.; Keating, M. J.; Wen, S.; Wierda, W. G.; O'Brien, S. M.; Faderl, S 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 137 KB

Bendamustine plus mitoxantrone for relap

Bendamustine plus mitoxantrone for relapsed/refractory chronic lymphocytic leukaemia (CLL): results of a multicentre phase II study of the German CLL Study Group (GCLLSG)

✍ Hubert Köppler; Harald Fuss; Hans J. Hurtz; Owe Knigge; Christoph Losem; Daniel 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Dasatinib in combination with fludarabin

Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: A multicenter phase 2 study

✍ Kater, Arnon P.; Spiering, Marjolein; Liu, Roberto D.; Doreen te Raa, G.; Slinge 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 894 KB

A phase I/II study of ofatumumab (GSK184

A phase I/II study of ofatumumab (GSK1841157) in Japanese and Korean patients with relapsed or refractory B-cell chronic lymphocytic leukemia

✍ Yoshiaki Ogawa, Michinori Ogura, Tatsuya Suzuki… 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 275 KB